Overview

Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance

Status:
Completed
Trial end date:
2017-04-11
Target enrollment:
Participant gender:
Summary
The goal of this study is to develop a non-invasive imaging test for in vivo detection of kidney transplant rejection. The hypotheses are that 1) Ferumoxytol-MRI can generate accurate estimates of tissue iron concentrations and tissue macrophages. 2) The signal given by a renal allograft on Ferumoxytol-MRI demonstrates significant differences between rejected and non-rejected transplants.
Phase:
N/A
Details
Lead Sponsor:
Stanford University
Collaborator:
Lucile Packard Children's Hospital
Treatments:
Ferrosoferric Oxide